Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administration (FDA) ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

Hospitals trumpet robotic surgery as innovation. Surgeons market it as progress. Manufacturers insist the technology is safe.

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

According to MarketsandMarkets™, the Surgical Robots Market is projected to grow from about USD 13.69 billion in 2025 to USD ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

Moving complex spine to ASCs saves 60%, but professionals warn that standard facilities aren't ready, as it takes ...

Tesla is poised for substantial revenue growth from Cybercab robotaxis and Optimus humanoid robots. See why I rate TSLA stock ...

Da Vinci 5 is a next-generation robotic-assisted surgical system and it has recently found a new home at Orange City Area ...